Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms
The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., et al. (2001) · Nature Genetics · doi:10.1038/86882 · Cited by 2,162
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
Guengerich, F. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.1 · Cited by 1,267
Gotoh, O. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48462-1 · Cited by 1,194
Weinshilboum, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020021 · Cited by 1,031
Rendic, S., & Carlo, F. J. D. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037591 · Cited by 949
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Moore, L. B., Goodwin, B., Jones, S. A., Wisely, G. B., Serabjit-Singh, C. J., Willson, T. M., Collins, J. L., & Kliewer, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130155097 · Cited by 947
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
Brian Houston, J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90520-7 · Cited by 925
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., & Sutter, T. R. (1996) · PubMed · Cited by 905
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
Geick, A., Eichelbaum, M., & Burk, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010173200 · Cited by 848
IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
Thummel, K. E., & Wilkinson, G. R. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.389 · Cited by 831
Modulation of oestrogen receptor signalling by association with the activated dioxin receptor
Ohtake, F., Takeyama, K.-I., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., et al. (2003) · Nature · doi:10.1038/nature01606 · Cited by 798
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 764
Bertz, R. J., & Granneman, G. R. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732030-00004 · Cited by 755
Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review
Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K., & Sadee, W. (2001) · JAMA · doi:10.1001/jama.286.18.2270 · Cited by 705
Mammalian Microsomal Cytochrome P450 Monooxygenase
Williams, P. A., Cosme, J., Sridhar, V., Johnson, E. F., & McRee, D. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80408-6 · Cited by 696
The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., & Negishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6043 · Cited by 668
Stoilov, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.641 · Cited by 647
Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjöqvist, F., & Ingelman-Sundberg, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11825 · Cited by 644
Self-citation17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 632
Tumor-specific expression of cytochrome P450 CYP1B1.
Murray, G. I., Taylor, M. C., McFadyen, M. C. E., McKay, J., Greenlee, W. F., Burke, M. D., & Melvin, W. T. (1997) · PubMed · Cited by 621
Cytochrome P450 3A: Ontogeny and Drug Disposition
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937060-00004 · Cited by 586
Lang, T., Klein, K., Fischer, J., Nussler, A. K., Neuhaus, P., Hofmann, U., Eichelbaum, M., Schwab, M. G., & Zanger, U. M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200107000-00004 · Cited by 574
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
Ingelman-Sundberg, M., Oscarson, M., & McLellan, R. A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01363-2 · Cited by 539
Self-citationAbdel-Razzak, Z., Loyer, P., Fautrel, A., Gautier, J. C., Corcos, L., Turlin, B., Beaune, P., & Guillouzo, A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13247-1 · Cited by 537
Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1
Peter, R., Boecker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., & Yang, C. S. (1990) · Chemical Research in Toxicology · doi:10.1021/tx00018a012 · Cited by 528
Ito, K., Iwatsubo, T., Kanamitsu, S., Ueda, K., Suzuki, H., & Sugiyama, Y. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01372-3 · Cited by 512
Regulation of cytochrome P450 (CYP) genes by nuclear receptors
Honkakoski, P., & Negishi, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470321 · Cited by 501
Özdemir, V., KALOW, W., Tang, B.-K., Paterson, A. D., Walker, S. E., Endrényi, L., & Kashuba, A. D. M. (2000) · Pharmacogenetics · doi:10.1097/00008571-200007000-00001 · Cited by 440
Regulation of the Human CYP2B6 Gene by the Nuclear Pregnane X Receptor
Goodwin, B., Moore, L. B., Stoltz, C. M., McKee, D. D., & Kliewer, S. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12603-x · Cited by 374
Inhibition and induction of human cytochrome P450 (CYP) enzymes
PELKONEN, O., MÄEENPÄEÄ, J., TAAVITSAINEN, P., RAUTIO, A., & RAUNIO, H. (1998) · Xenobiotica · doi:10.1080/004982598238886 · Cited by 358
Faucette, S. R., Hawke, R. L., Lecluyse, E. L., Shord, S. S., Yan, B., Laethem, R. M., & Lindley, C. M. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12054-8 · Cited by 353
Characterization of Human Small Intestinal Cytochromes P-450
Zhang, Q.-Y., Dunbar, D., Ostrowska, A., Zeisloft, S., Yang, J., & Kaminsky, L. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15229-4 · Cited by 343
CYP3A4 drug interactions: correlation of 10 in vitro probe substrates
Kenworthy, Bloomer, Clarke, & Houston (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00073.x · Cited by 336
Regulation, Function, and Tissue-Specific Expression of Cytochrome P450 CYP1B1
Murray, G. I., Melvin, W. T., Greenlee, W. F., & Burke, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.297 · Cited by 336
Eagling, V. A., Back, D. J., & Barry, M. G. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00644.x · Cited by 333
Interindividual Variability and Tissue-Specificity in the Expression of Cytochrome P450 3A mRNA
Koch, I., Weil, R., Wolbold, R., Brockmöller, J., Hustert, E., Burk, O., Nuessler, A., Neuhaus, P., Eichelbaum, M., Zanger, U., et al. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.10.1108 · Cited by 314
Westlind, A., Löfberg, L., Tindberg, N., Andersson, T. B., & Ingelman-Sundberg, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0752 · Cited by 300
Self-citationSong, B. J., Veech, R. L., Park, S. S., Gelboin, H. V., & Gonzalez, F. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94103-7 · Cited by 277
Catalytic properties of polymorphic human cytochrome P450 1B1 variants
Shimada, T. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1607 · Cited by 270
Ethanol Induces CYP2E1 by Protein Stabilization
Roberts, B. J., Song, B.-J., Soh, Y., Park, S. S., & Shoaf, S. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29632 · Cited by 267
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6
Zanger, U. M., Fischer, J., Raimundo, S., Stüven, T., Evert, B. O., Schwab, M., & Eichelbaum, M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200110000-00004 · Cited by 266
Human CYP2B6: expression, inducibility and catalytic activities
Gervot, L., Rochat, B., Gautier, J. C., Bohnenstengel, F., Kroemer, H., de Berardinis, V., Martin, H., Beaune, P., & de Waziers, I. (1999) · Pharmacogenetics · doi:10.1097/00008571-199906000-00004 · Cited by 265
Floyd, M. D., Gervasini, G., Masica, A. L., Mayo, G., George, A. L., Bhat, K., Kim, R. B., & Wilkinson, G. R. (2003) · Pharmacogenetics · doi:10.1097/00008571-200310000-00003 · Cited by 261
Identification and functional characterization of eight CYP3A4 protein variants.
Eiselt, R., Domanski, T. L., Zibat, A., Mueller, R., Presecan, E., Hustert, E., Zanger, U. M., Brockmöller, J., Klenk, H., Meyer, U., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200107000-00008 · Cited by 261
Westlind-Johnsson, A., Malmebo, S., Johansson, A., Otter, C., Andersson, T. B., Johansson, I., Edwards, R. J., Boobis, A. R., & Ingelman-Sundberg, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.755 · Cited by 258
Self-citationGibbs, M. A., Thummel, K. E., Shen, D. D., & Kunze, K. L. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15274-9 · Cited by 245
Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy
Ingelman‐Sundberg, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00879.x · Cited by 242
Self-citationRao, Y., Hoffmann, E., Zia, M., Bodin, L., Zeman, M., Sellers, E. M., & Tyndale, R. F. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23106-0 · Cited by 231
Isolation and Characterization of the Human Cytochrome P450 CYP1B1 Gene
Tang, Y. M., Wo, Y.-Y. P., Stewart, J., Hawkins, A. L., Griffin, C. A., Sutter, T. R., & Greenlee, W. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28324 · Cited by 229
Harlow, G. R., & Halpert, J. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6636 · Cited by 228
Zonation of hepatic cytochrome P-450 expression and regulation
OINONEN, T., & LINDROS, O. K. (1998) · Biochemical Journal · doi:10.1042/bj3290017 · Cited by 227
Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene
Gellner, K., Eiselt, R., Hustert, E., Arnold, H., Koch, I., Haberl, M., Deglmann, C. J., Burk, O., Buntefuss, D., Escher, S., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200103000-00002 · Cited by 226
Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4.
Hustert, E., Zibat, A., Presecan, E., Eiselt, R., Mueller, R., Fuss, C., Brehm, I., Brinkmann, U., Eichelbaum, M. F., Wojnowski, L., et al. (2001) · PubMed · Cited by 218
Jover, R. (2001) · Hepatology · doi:10.1053/jhep.2001.22176 · Cited by 216
HASHIMOTO, H., TOIDE, K., KITAMURA, R., FUJITA, M., TAGAWA, S., ITOH, S., & KAMATAKI, T. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18412.x · Cited by 209
Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
Yanagihara, Y., Kariya, S., Ohtani, M., Uchino, K., Aoyama, T., Yamamura, Y., & Iga, T. (2001) · PubMed · Cited by 209
Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver
Hakkola, J., Pasanen, M., Purkunen, R., Saarikoski, S., Pelkonen, O., Mäenpää, J., Rane, A., & Raunio, H. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90223-2 · Cited by 206
cDNA Cloning and Initial Characterization of CYP3A43, a Novel Human Cytochrome P450
Domanski, T. L., Finta, C., Halpert, J. R., & Zaphiropoulos, P. G. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12850-7 · Cited by 205
Cloning and Tissue Distribution of a Novel Human Cytochrome P450 of the CYP3A Subfamily, CYP3A43
Westlind, A., Malmebo, S., Johansson, I., Otter, C., Andersson, T. B., Ingelman-Sundberg, M., & Oscarson, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4505 · Cited by 178
Self-citationFurther Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
Ekins, S., Vandenbranden, M., Ring, B. J., Gillespie, J. S., Yang, T. J., Gelboin, H. V., & Wrighton, S. A. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37719-5 · Cited by 178
Muskhelishvili, L., Thompson, P. A., Kusewitt, D. F., Wang, C., & Kadlubar, F. F. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900210 · Cited by 177
THE ROLE OF CYP2B6 IN HUMAN XENOBIOTIC METABOLISM*
EKINS, S., & WRIGHTON, S. A. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101942 · Cited by 176
Centrilobular expression of ethanol-inducible cytochrome P-450 (IIE1) in rat liver
Ingelman-Sundberg, M., Johansson, I., Penttilä, K. E., Glaumann, H., & Lindros, K. O. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80010-x · Cited by 175
Self-citationEliasson, E., Johansson, I., & Ingelman-Sundberg, M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90539-6 · Cited by 172
Self-citationCharacterisation of CYP3A gene subfamily expression in human gastrointestinal tissues.
McKinnon, R. A., Burgess, W. M., Hall, P. M., Roberts‐Thomson, S. J., Gonzalez, F. J., & McManus, M. E. (1995) · Gut · doi:10.1136/gut.36.2.259 · Cited by 169
McCarver, D. G., Byun, R., Hines, R. N., Hichme, M., & Wegenek, W. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8532 · Cited by 167
Engineering Microsomal Cytochrome P450 2C5 to Be a Soluble, Monomeric Enzyme
Cosme, J., & Johnson, E. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2545 · Cited by 167
Human cytochrome P-450 enzymes
Guengerich, F. P. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90136-d · Cited by 162
In vitro and pharmacophore insights into CYP3A enzymes
Ekins, S., Stresser, D. M., & Williams, J. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00049-x · Cited by 161
Genetic Polymorphism of Human CYP2E1: Characterization of Two Variant Alleles
Hu, Y., Oscarson, M., Johansson, I., Yue, Q., Dahl, M., Tabone, M., Arincò, S., Albano, E., & Ingelman‐Sundberg, M. (1997) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13476-1 · Cited by 155
Self-citationSmith, G. C., Wolf, C. R., Deeni, Y., Dawe, R. S., Evans, A. T., Comrie, M., Ferguson, J., & Ibbotson, S. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13081-4 · Cited by 153
Functional Characterization of Cytochrome P450 2B6 Allelic Variants
Jinno, H., Tanaka‐Kagawa, T., Ohno, A., Makino, Y., Matsushima, E., Hanioka, N., & Ando, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.4.398 · Cited by 152
Identification of a novel dioxin-inducible cytochrome P450
Rivera, S. P., Saarikoski, S. T., & Hankinson, O. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12856-8 · Cited by 149
Robin, M.-A., Anandatheerthavarada, H. K., Biswas, G., Sepuri, N. B. V., Gordon, D. M., Pain, D., & Avadhani, N. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203292200 · Cited by 147
A Combination of Mutations in the CYP2D6*17(CYP2D6Z) Allele Causes Alterations in Enzyme Function
Oscarson, M., Hidestrand, M., Johansson, I., & Ingelman‐Sundberg, M. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1034 · Cited by 141
Self-citationSubstrate-, hormone-, and cAMP-regulated cytochrome P450 degradation.
Eliasson, E., Johansson, I., & Ingelman‐Sundberg, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3225 · Cited by 134
Self-citationKinirons, M. T., O’Shea, D., Kim, R. B., Groopman, J. D., Thummel, K. E., Wood, A. J. J., & Wilkinson, G. R. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70029-9 · Cited by 134
Aklillu, E., Oscarson, M., Hidestrand, M., Leidvik, B., Otter, C. A., & Ingelman‐Sundberg, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.3.586 · Cited by 133
Self-citationSignal Transduction-mediated Activation of the Aryl Hydrocarbon Receptor in Rat Hepatoma H4IIE Cells
Backlund, M., Johansson, I., Mkrtchian, S., & Ingelman‐Sundberg, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31755 · Cited by 123
Self-citationDanielson, P. B., MacIntyre, R., & Fogleman, J. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10797 · Cited by 120
Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9
Simonsson, U. S. H., Jansson, B., Hai, T. N., Huong, D. X., Tybring, G., & Ashton, M. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00092-4 · Cited by 119
Evidence of Proteasome-mediated Cytochrome P-450 Degradation
Roberts, B. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9771 · Cited by 116
Rae, J. M., Soukhova, N. V., Flockhart, D. A., & Desta, Z. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.525 · Cited by 113
Robin, M.-A., Anandatheerthavarada, H. K., Fang, J.-K., Cudic, M., Otvos, L., & Avadhani, N. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100363200 · Cited by 107
Identification and Tissue Distribution of the Novel Human Cytochrome P450 2S1 (CYP2S1)
Rylander‐Rudqvist, T., Neve, E. P. A., Ingelman‐Sundberg, M., & Oscarson, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4390 · Cited by 106
Self-citationStudy of P450 function using gene knockout and transgenic mice
Gonzalez, F. J., & Kimura, S. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00364-8 · Cited by 102
The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
Kliewer, S. A., Lehmann, J. M., Milburn, M. V., & Willson, T. M. (1999) · PubMed · Cited by 102
Involvement of human liver cytochrome P4502B6in the metabolism of propofol
Oda, Y., Hamaoka, N., Hiroi, T., Imaoka, S., Hase, I., TANAKA, K. A., Funae, Y., Ishizaki, T., & Asada, A. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.00344.x · Cited by 99
Afzelius, L., Zamora, I., Ridderström, M., Andersson, T. B., Karlén, A., & Masimirembwa, C. M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09261-7 · Cited by 98
Gebhardt, A. C., Lucas, D., Menez, J. F., & Seitz, H. K. (1997) · Hepatology · doi:10.1002/hep.510260423 · Cited by 96
Zhukov, A., & Ingelman‐Sundberg, M. (1999) · Biochemical Journal · doi:10.1042/bj3400453 · Cited by 94
Self-citationHu, Y., Hakkola, J., Oscarson, M., & Ingelman‐Sundberg, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1362 · Cited by 90
Self-citationTranscriptional control of CYP2E1 in the perivenous liver region and during starvation
Johansson, I., Lindros, K. O., Eriksson, H., & Ingelman‐Sundberg, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81061-7 · Cited by 90
Self-citationWrighton, S. A., & VandenBranden, M. R. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90575-4 · Cited by 84
Fukuda, T., Nishida, Y., Imaoka, S., Hiroi, T., Naohara, M., Funae, Y., & Azuma, J. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1936 · Cited by 82
De Waziers, I., Garlatti, M., Bouguet, J., Beaune, P. H., & Barouki, R. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08567-0 · Cited by 78
Molecular Basis for the Transport of Cytochrome P450 2E1 to the Plasma Membrane
Neve, E. P. A., & Ingelman-Sundberg, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000957200 · Cited by 71
Self-citationRoy, P., Tretyakov, O., Wright, J., et al. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14934-3 · Cited by 71
Ohmori, S., Nakasa, H., Asanome, K., Kurose, Y., Ishii, I., Hosokawa, M., & Kitada, M. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00156-6 · Cited by 70
Pelkonen, O., Myllynen, P. K., Taavitsainen, P., Boobis, A. R., Watts, P. S., Lake, B. G., Price, R. J., Renwick, A. B., Gómez‐Lechón, M. J., Castell, J. V., et al. (2001) · Xenobiotica · doi:10.1080/00498250110055479 · Cited by 61
Self-citationHuman cytochrome P-450 (CYP) genes: A web page for the nomenclature of alleles
Ingelman‐Sundberg, M., Oscarson, M., Daly, A. K., GARTE, S. J., & Nebert, D. W. (2001) · PubMed · doi:10.25405/ncl.34646841 · Cited by 59
Self-citationFaucette, S. R., Hawke, R. L., Shord, S. S., LeCluyse, E. L., & Lindley, C. M. (2001) · PubMed · Cited by 56
Andersson, T. B., Sjöberg, H., Hoffmann, K., Boobis, A. R., Watts, P. S., Edwards, R. J., Lake, B. G., Price, R. J., Renwick, A. B., Gómez-Lechón, M. J., et al. (2001) · PubMed · Cited by 50
Self-citationGillam, E. M. J., Wunsch, R. M., Ueng, Y., Shimada, T., Reilly, P. E. B., Kamataki, T., & Guengerich, F. P. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0286 · Cited by 47
Neve, E. P. A., & Ingelman-Sundberg, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008640200 · Cited by 47
Self-citationTranscriptional and Post-Translational Regulation of CYP1A1 by Primaquine
Werlinder, V., Backlund, M., Zhukov, A., & Ingelman‐Sundberg, M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29529-x · Cited by 41
Self-citationJossic-Corcos, C. L., Glaise, D., Corcos, L., Diot, C., Dezier, J. F., Fautrel, A., & Guguen‐Guillouzo, C. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0400z.x · Cited by 36
Cited by
Ingelman-Sundberg, M. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500285 · Cited by 1,108
Self-citationCytochrome P450 Enzymes and Drug Metabolism in Humans
Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., He, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312808 · Cited by 1,070
Oxidative Stress and Oxidative Damage in Carcinogenesis
Klaunig, J. E., Kamendulis, L. M., & Hocevar, B. A. (2010) · Toxicologic Pathology · doi:10.1177/0192623309356453 · Cited by 957
Ingelman-Sundberg, M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.007 · Cited by 676
Self-citationCytochrome P450 pharmacogenetics and cancer
Rodriguez-Antona, C., & Ingelman-Sundberg, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209377 · Cited by 575
Self-citation
Metadata
- Authors
- Ingelman-Sundberg, M.
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2004-01-01
- Volume
- 369
- Issue
- 1
- Pages
- 89-104
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2030975106
- Cited by
- 353
- References
- 112
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.